Downregulation of galectin-3 by EGF mediates the apoptosis of HepG2 cells

Molecular and Cellular Biochemistry

Volumn 369, Issue 1-2, 2012, Pages 157-165

  Hu, Zhenzhen ^a   Jiang, Xiuqin ^a   Xu, Ying ^a   Lu, Nan ^b   Wang, Weizhi ^a   Luo, Jie ^a   Zou, Han ^a   Zheng, Datong ^a   Feng, Xing ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Epidermal growth factor receptor; Extracellular regulated protein kinases; Galectin 3; Protein kinase B

Indexed keywords

EPIDERMAL GROWTH FACTOR; GALECTIN 3;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CYTOPLASM; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

APOPTOSIS; EPIDERMAL GROWTH FACTOR; GALECTIN 3; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; MCF-7 CELLS; PHOSPHORYLATION;

EID: 84865616332     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1378-8     Document Type: Article

References (37)

1. J Schlessinger 2000 Cell signaling by receptor tyrosine kinases Cell 103 211 225 11057895 10.1016/S0092-8674(00)00114-8 1:CAS:528:DC%2BD3cXns1Cltrs%3D
2. MD Marmor KB Skaria Y Yarden 2004 Signal transduction and oncogenesis by ErbB/HER receptors Int J Radiat Oncol Biol Phys 58 903 913 14967450 10.1016/j.ijrobp.2003.06.002 1:CAS:528:DC%2BD2cXhtVyhu74%3D (Pubitemid 38221150)
3. F Milanezi S Carvalho FC Schmitt 2008 EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy Expert Rev Mol Diagn 8 417 434 18598224 10.1586/14737159.8.4.417 1:CAS:528:DC%2BD1cXotFOqt78%3D (Pubitemid 351962088)
4. R Marais CJ Marshall 1996 Control of the ERK MAP kinase cascade by Ras and Raf Cancer Surv 27 101 125 8909797 1:CAS:528:DyaK28XntlSns7k%3D (Pubitemid 26363825)
5. N Normanno AD Lua C Bianco L Strizzi M Mancino MR Maiello A Carotenuto G De Feo F Caponigro DS Salomon 2006 Epidermal growth factor receptor (EGFR) signaling in cancer Gene 366 2 16 16377102 10.1016/j.gene.2005.10.018 1:CAS:528:DC%2BD28Xht1Crs7k%3D (Pubitemid 43199589)
6. G Lurje HJ Lenze 2009 EGFR signaling and drug discovery Oncology 77 400 410 20130423 10.1159/000279388 1:CAS:528:DC%2BC3cXit1Ont70%3D
7. T Kawamoto J Mendelsohn A Le GH Sato CS Lazar GN Gill 1984 Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells J Biol Chem 259 7761 7766 6330080 1:CAS:528: DyaL2cXksV2htbk%3D (Pubitemid 14081191)
8. DK Armstrong SH Kaufmann YL Ottaviano Y Furuya JA Buckley JT Isaacs NE Davidson 1994 Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells Cancer Res 54 5280 5283 7923154 1:CAS:528:DyaK2cXmsFakt78%3D (Pubitemid 24336014)
9. R Garcia RA Franklin JA McCubrey 2006 Cell death of MCF-7 human breast cancer cells induced by EGFR activation in the absence of other growth factors Cell Cycle 5 1840 1846 16861904 10.4161/cc.5.16.3016 1:CAS:528: DC%2BD28Xht1Gnt7vK (Pubitemid 44435328)
10. PS Grudinkin VV Zenin AV Kropotov VN Dorosh NN Nikolsky 2007 EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3 Eur J Cell Biol 86 591 603 17646016 10.1016/j.ejcb.2007.05.009 1:CAS:528:DC%2BD2sXht1ygtbfM (Pubitemid 47408712)
11. H Leffler S Carlsson M Hedlund Y Qian F Poirier 2004 Introduction to galectins Glycoconj J 19 433 440 14758066 10.1023/B:GLYC.0000014072.34840.04 (Pubitemid 38316516)
12. F Van de Brule S Califices V Castronovo 2004 Expression of galectins in cancer: a critical review Glycoconj J 19 537 542 14758077 10.1023/B:GLYC. 0000014083.48508.6a
13. FT Liu RJ Patterson JL Wang 2002 Intracellular functions of galectins Biochim Biophys Acta 1572 263 273 12223274 10.1016/S0304-4165(02)00313-6 1:CAS:528:DC%2BD38XmvVagsLk%3D (Pubitemid 35246349)
14. KK Hoyer M Pang D Gui IP Shintaku I Kuwabara FT Liu JW Said LG Baum MA Teitell 2004 An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas Am J Pathol 164 893 902 14982843 10.1016/S0002-9440(10)63177-X 1:CAS:528:DC%2BD2cXitl2jtrY%3D (Pubitemid 38235471)
15. Y Takenaka T Fukumori T Yoshii N Oka H Inohara HR Kim RS Bresalier A Raz 2004 Nuclear export of phodphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs Mol Cell Biol 24 4395 4406 15121858 10.1128/MCB.24.10.4395-4406.2004 1:CAS:528:DC%2BD2cXjvFChtLY%3D (Pubitemid 41071009)
16. F Yu RL Finley HR Kim 2002 Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation J Biol Chem 277 15819 15827 11839755 10.1074/jbc.M200154200 1:CAS:528:DC%2BD38Xjs1Wjsbg%3D (Pubitemid 34967860)
17. FT Liu GA Rabinovich 2005 Galectins as modulators of tumor progression Nat Rev Cancer 5 29 39 15630413 10.1038/nrc1527 1:CAS:528:DC%2BD2MXlvVem (Pubitemid 40052323)
18. G Elad-Sfadia R Haklai E Ballan Y Kloog 2004 Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phodphoinositide 3-kinase activity J Biol Chem 279 34922 34930 15205467 10.1074/jbc.M312697200 1:CAS:528:DC%2BD2cXmvFemsbY%3D (Pubitemid 39318128)
19. JA Krall EM Beyer G MacBeath 2011 High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways PLoS One 6 e15945 21264347 10.1371/journal.pone.0015945 1:CAS:528: DC%2BC3MXhtVSisbk%3D
20. EB Yang DF Wang P Mack LY Cheng 1996 EGF receptor in human Chang liver and hepatoma HepG2 cells Mol Biol Int 38 813 820 1:CAS:528:DyaK2sXlvVajsQ%3D%3D
21. K Yamauchi JE Pessin 1995 Epidermal growth factor-induced association of the SHPTP2 protein tyrosine phosphatase with a 115-kDa phosphotyrosine protein J Biol Chem 270 14871 14874 7541031 10.1074/jbc.270.25.14871 1:CAS:528: DyaK2MXmsFKqsrc%3D
22. CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation J Cell Biochem 204 176 188 10.1002/jcb.21614
23. J Zhuge AI Cederbaum 2006 Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1 Free Radic Biol Med 40 63 74 16337880 10.1016/j. freeradbiomed.2005.08.012 1:CAS:528:DC%2BD2MXhtlSiu7rK (Pubitemid 41759404)
24. CJ Schamberger C Gerner C Cerni 2005 Caspase-9 plays a marginal role in serum starvation-induced apoptosis Exp Cell Res 302 115 128 15541731 10.1016/j.yexcr.2004.08.026 1:CAS:528:DC%2BD2cXpslWmsrw%3D (Pubitemid 39482373)
25. T Takehara X Liu J Fujimoto SL Friedman H Takahashi 2001 Expression and role of Bcl-xL in human hepatocellular carcinomas Hepatology 34 55 61 11431734 10.1053/jhep.2001.25387 1:CAS:528:DC%2BD3MXltlKjs7w%3D (Pubitemid 32591483)
26. X Wu T Daniels C Molinaro MB Lilly CA Casiano 2002 Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its prosurvival function: implications for autoimmunity in atopic disorders Cell Death Differ 9 915 925 12181742 10.1038/sj.cdd.4401063 1:CAS:528:DC%2BD38XmtVOmsr8%3D (Pubitemid 35023607)
27. S Kang J Song H Kang S Kim Y Lee D Park 2003 Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells Eur J Endocrinol 148 147 155 12534368 10.1530/eje.0.1480147 1:CAS:528:DC%2BD3sXptVKlsQ%3D%3D (Pubitemid 36176015)
28. DK Hsu FT Liu 2004 Regulation of cellular homeostasis by galectins Glycoconj J 19 507 515 14758074 10.1023/B:GLYC.0000014080.95829.52 (Pubitemid 38316524)
29. S Nakahara N Oka A Raz 2005 On the role of galectin-3 in cancer apoptosis Apoptosis 10 267 275 15843888 10.1007/s10495-005-0801-y 1:CAS:528: DC%2BD2MXjtl2ktL4%3D (Pubitemid 40603482)
30. W Kolch 2000 Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions Biochem J 351 289 305 11023813 10.1042/0264-6021:3510289 1:CAS:528:DC%2BD3cXnvFSqt78%3D
31. JA McCubrey LS Steelman SL Abrams 2006 Roles of the RAF/MEK/ERK and PI3K/PETN/AKT pathways in malignant transformation and drug resistance Adv Enzyme Regul 46 249 279 16854453 10.1016/j.advenzreg.2006.01.004 1:CAS:528:DC%2BD1cXhs12lurs%3D (Pubitemid 44301348)
32. HR Kim HM Lin H Briliran A Raz 1999 Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells Cancer Res 59 148 4154
33. HM Lin G Pestell A Raz HR Kim 2002 Galectin-3 enhanced cyclin D, promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells Oncogene 21 8001 8010 12439750 10.1038/sj.onc.1205820 1:CAS:528: DC%2BD38XoslGlsLw%3D (Pubitemid 35430611)
34. WAF1/CIP1 mediated by STAT Science 272 719 722 8614832 10.1126/science.272.5262.719 1:CAS:528:DyaK28Xislamtrs%3D
35. RJ Anto M Venkatraman D Karunagaran 2003 Inhibition of NF-κB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance J Biol Chem 278 25490 25498 12714587 10.1074/jbc.M301790200 1:CAS:528:DC%2BD3sXlt1Cmtbc%3D (Pubitemid 36835300)
36. S Califice V Castronovo M Bracke F Van Den Brule 2004 Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 Oncogene 23 7527 7536 15326483 10.1038/sj.onc.1207997 1:CAS:528:DC%2BD2cXnvFGkur4%3D (Pubitemid 39389694)
37. I Paron 2003 Nuclear localization of galectin-3 in transformed thyroid cells: a role in transcriptional regulation Biochem Biophys Res Commun 302 545 553 12615069 10.1016/S0006-291X(03)00151-7 1:CAS:528:DC%2BD3sXhs1Kgsrw%3D (Pubitemid 36279565)